APA

Basch E. M., Scholz M., de Bono J. S., Vogelzang N., de Souza P., Marx G., Vaishampayan U., George S., Schwarz J. K., Antonarakis E. S., O'Sullivan J. M., Kalebasty A. R., Chi K. N., Dreicer R., Hutson T. E., Dueck A. C., Bennett A. V., Dayan E., Mangeshkar M., Holland J., Weitzman A. L. & Scher H. I. (20200723). Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint. : European urology.

Chicago

Basch Ethan M, Scholz Mark, de Bono Johann S, Vogelzang Nicholas, de Souza Paul, Marx Gavin, Vaishampayan Ulka, George Saby, Schwarz James K, Antonarakis Emmanuel S, O'Sullivan Joseph M, Kalebasty Arash Rezazadeh, Chi Kim N, Dreicer Robert, Hutson Thomas E, Dueck Amylou C, Bennett Antonia V, Dayan Erica, Mangeshkar Milan, Holland Jaymes, Weitzman Aaron L and Scher Howard I. 20200723. Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint. : European urology.

Harvard

Basch E. M., Scholz M., de Bono J. S., Vogelzang N., de Souza P., Marx G., Vaishampayan U., George S., Schwarz J. K., Antonarakis E. S., O'Sullivan J. M., Kalebasty A. R., Chi K. N., Dreicer R., Hutson T. E., Dueck A. C., Bennett A. V., Dayan E., Mangeshkar M., Holland J., Weitzman A. L. and Scher H. I. (20200723). Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint. : European urology.

MLA

Basch Ethan M, Scholz Mark, de Bono Johann S, Vogelzang Nicholas, de Souza Paul, Marx Gavin, Vaishampayan Ulka, George Saby, Schwarz James K, Antonarakis Emmanuel S, O'Sullivan Joseph M, Kalebasty Arash Rezazadeh, Chi Kim N, Dreicer Robert, Hutson Thomas E, Dueck Amylou C, Bennett Antonia V, Dayan Erica, Mangeshkar Milan, Holland Jaymes, Weitzman Aaron L and Scher Howard I. Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint. : European urology. 20200723.